Cadisegliatin
Cadisegliatin is a pharmaceutical drug used in the treatment of type 2 diabetes. It belongs to the class of drugs known as glucokinase activators, which work by increasing the activity of the enzyme glucokinase in the body. This enzyme plays a crucial role in the regulation of blood glucose levels, making it a target for the treatment of diabetes.
Mechanism of Action[edit | edit source]
The primary mechanism of action of Cadisegliatin involves the activation of glucokinase, an enzyme that facilitates the conversion of glucose to glucose-6-phosphate. This process is a key step in the glycolysis pathway, which is responsible for the breakdown of glucose in the body. By increasing the activity of glucokinase, Cadisegliatin enhances the rate of glycolysis, leading to a reduction in blood glucose levels.
Clinical Use[edit | edit source]
Cadisegliatin is primarily used in the management of type 2 diabetes, a chronic condition characterized by high blood glucose levels. It is typically prescribed as part of a comprehensive treatment plan that also includes diet, exercise, and other medications. The drug is usually taken orally, with the dosage determined by the patient's individual needs and response to treatment.
Side Effects[edit | edit source]
Like all medications, Cadisegliatin can cause side effects. The most common side effects include nausea, diarrhea, and abdominal pain. In rare cases, the drug can cause more serious side effects such as hypoglycemia (low blood sugar) and liver problems. Patients are advised to report any unusual or severe side effects to their healthcare provider.
Research and Development[edit | edit source]
Cadisegliatin was developed through extensive research and clinical trials. Early studies focused on its mechanism of action and potential benefits in the treatment of diabetes. Later trials evaluated its safety and efficacy in larger patient populations. The results of these trials formed the basis for its approval by regulatory authorities.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
